GlassScriptPhysician profile
Margaret Gossett
NPI 1104843036
$1,601.52
in general payments reported to CMS, 2019-2025
20 companies · $483 in 2025
The $483 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $204 · 2023: $499 · 2024: $416 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.44 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $204.92 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Millicent US INC | $204.33 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Astellas Pharma US INC | $176.73 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $130.40 | 2022-2025 | |
| Exeltis, USA INC. | $123.87 | 2022-2025 | Slynd |
| Abbvie INC. | $114.87 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $107.37 | 2023-2025 | |
| Biogen, INC. | $103.93 | 2024-2025 | Zurzuvae |
| Organon LLC | $102.88 | 2022-2023 | Nexplanon |
| Coopersurgical, INC. | $100.47 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Shield Therapeutics INC | $57.55 | 2025 | |
| Merck Sharp & Dohme LLC | $32.64 | 2023-2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $21.45 | 2025 | Cologuard Collection Kit |
| Dexcom, INC. | $21.35 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $20.75 | 2023 | Wegovy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $16.68 | 2023 | Citranatal |
| Medicem INC. | $16.19 | 2023 | |
| Olympus America INC. | $16.09 | 2024 | Olympus |
| Avion Pharmaceuticals | $14.81 | 2023 | Balcoltra |
| Gynesonics, INC. | $14.24 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Gossett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.